Cancer Diagnosis Downloads
-
Enzymes for Producing Free Fatty Acid Assay Kits
Free fatty acids(FFA, monoacylglycerols and diacylglycerols) are derived from triacylglycerol by cleavage of ester bonds due to the action of lipase, high temperature, and moisture. Measurement of free fatty acids has become useful in monitoring and diagnosing various diseases and metabolic disorders (e.g., obesity, insulin resistance, diabetes, cancer). ...
-
Semi-Robotic Arm System - Brochure
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm of the Fusion Bx allows you to effortlessly maneuver the probe to accurately locate and target suspicious regions of interest. An unrestricted range of motion allows freehand-like access to the entire ...
-
Celemics OncoRisk - Panel - Datasheet
Comprehensive analysis of oncogenes: Analyze 31 oncogenes associated with inherited cancer and precisely selected from contract research organizations and numerous research ...
-
Tempus xG - Brochure
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
By Tempus
-
The Reasons for Choosing Our Cancer Panels
CD Genomics's cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. ...
By CD Genomics
-
Custom NGS Panel
Based on rich experience in targeted sequencing, CD Genomics has developed a Disease Panel platform for targeted sequencing of disease-related genes to help researchers with cancer diagnostics and analysis, pathogen detection, and pharmacogenomics testing. ...
By CD Genomics
-
OncoDEEP Brochure
Oncodeep® is a comprehensive biomarker test designed to guide treatment of advanced, metastatic solid tumors. When your patients are diagnosed with a rare cancer type or an aggressive cancer, when chemotherapy doesn't work or when cancer comes back, OncoDEEP® can provide you with clear clinical guidance. Starting from a small sample of tumor tissue, our biomarker test is able to pinpoint ...
By OncoDNA S.A.
-
Explore Cancer-related Mutations Using NGS
Cancer is primarily caused by genetic alterations, which may be inherited or acquired in somatic cells. These alterations in oncogenes, tumour suppressor genes or DNA repair genes may enable cells to evade growth inhibition in response to growth-inhibitory signals, leading to the development of a ...
By CD Genomics
-
Cancer Diagnostics Brochure
Identify clinically significant mutations in cancer-associated genes to optimize patient-specific ...
-
Caprico - Model EAPII - Anti-Unconjugated- Brochure
EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP ...
-
Ichroma - Model II - Advanced Compact Immuno-Analyzer - Brochure
ichroma II is an automatic or semiautomatic in-vitro diagnostic device that measures the concentration of analytes, contained in blood, urine, or other samples, in quantitative or semi-quantitative ways. Compared to the fi rstgeneration device, ichroma™, ichroma™ II has an improved user interface and display and an advanced optical system, which provide the user with disease test ...
-
Biocept - Model EGFR -CE IVD - Target Selector Mutation Test Kit - Brochure
Biocept’s Target Selector™ molecular assay kits detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded (FFPE) tissue gained from surgical biopsies as well as circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies. The EGFR pathway can include mutations that are among the most frequently evaluated biomarkers for lung ...
By Biocept
-
Contract Research Services
BioscienceContraCt researChCONSISTENCYa Customized approach SoBran contract research services and our design-built laboratory can meet your specific small-animal preclinical toxicology and drug discovery program needs. We work with each of our clients to ensure that their research efforts are conducted in the most professional and effective manner and maintain the highest levels of quality ...
By SoBran Inc.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you